Details for New Drug Application (NDA): 211625
✉ Email this page to a colleague
The generic ingredient in SUCCINYLCHOLINE CHLORIDE is succinylcholine chloride. There are six drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
Summary for 211625
Tradename: | SUCCINYLCHOLINE CHLORIDE |
Applicant: | Umedica |
Ingredient: | succinylcholine chloride |
Patents: | 0 |
Pharmacology for NDA: 211625
Physiological Effect | Neuromuscular Depolarizing Blockade |
Medical Subject Heading (MeSH) Categories for 211625
Suppliers and Packaging for NDA: 211625
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 211625 | ANDA | Nivagen Pharmaceuticals, Inc. | 75834-151 | 75834-151-25 | 25 VIAL, MULTI-DOSE in 1 TRAY (75834-151-25) / 10 mL in 1 VIAL, MULTI-DOSE (75834-151-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
Approval Date: | May 19, 2020 | TE: | AP | RLD: | No |
Complete Access Available with Subscription